Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | DKNG | Class A Common Stock | Sale | -$11.6M | -301K | -13.13% | $38.43 | 1.99M | Jun 25, 2024 | Held by the Paul Liberman 2015 Revocable Trust | F1, F2 |
transaction | DKNG | Class A Common Stock | Sale | -$11.7M | -299K | -15.04% | $39.25 | 1.69M | Jun 25, 2024 | Held by the Paul Liberman 2015 Revocable Trust | F1, F3 |
transaction | DKNG | Class A Common Stock | Sale | -$1.72M | -44.8K | -16.3% | $38.43 | 230K | Jun 25, 2024 | Held by the Paul Liberman 2020 Trust | F1, F4 |
transaction | DKNG | Class A Common Stock | Sale | -$939K | -23.9K | -10.39% | $39.32 | 206K | Jun 25, 2024 | Held by the Paul Liberman 2020 Trust | F1, F5 |
transaction | DKNG | Class A Common Stock | Options Exercise | $55.7K | +88.4K | +5.23% | $0.63* | 1.78M | Jun 26, 2024 | Held by the Paul Liberman 2015 Revocable Trust | F6 |
holding | DKNG | Class A Common Stock | 780K | Jun 25, 2024 | Direct | ||||||
holding | DKNG | Class A Common Stock | 214K | Jun 25, 2024 | Held by the Paul Liberman 2020 Irrevocable Trust | ||||||
holding | DKNG | Class A Common Stock | 200K | Jun 25, 2024 | Held by the Rachel Nager Liberman Irrevocable Trust - 2022 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | DKNG | Stock Option | Options Exercise | $0 | -88.4K | -100% | $0.00* | 0 | Jun 26, 2024 | Class A Common Stock | 88.4K | $0.63 | Held by the Paul Liberman 2015 Revocable Trust | F7 |
holding | DKNG | Stock Option | 74.1K | Jun 25, 2024 | Class A Common Stock | 88.4K | $0.63 | Direct | F7, F8 | |||||
holding | DKNG | Stock Option | 88.4K | Jun 25, 2024 | Class A Common Stock | 88.4K | $0.63 | Held by the Paul Liberman 2015 Revocable Trust | F7, F8 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Id | Content |
---|---|
F1 | The reported sales were made pursuant to a pre-arranged program for selling shares of Class A Common Stock adopted on March 5, 2024 pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934. |
F2 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.98 to $38.97, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes 2, 3, 4 and 5 to this Form 4. |
F3 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.98 to $39.80, inclusive. See the last sentence of footnote 2 to this Form 4 above. |
F4 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.98 to $38.95, inclusive. See the last sentence of footnote 2 to this Form 4 above. |
F5 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.99 to $39.80, inclusive. See the last sentence of footnote 2 to this Form 4 above. |
F6 | The Reporting Person acquired shares of Class A Common Stock of the Issuer upon the exercise of stock options and payment of the aggregate exercise price in cash. |
F7 | These stock options were granted on February 10, 2016. As of the date hereof, all such remaining stock options have vested. |
F8 | 88,441 stock options previously reported as held directly by the Reporting Person. There was no purchase or sale in connection with the transfer to the trust. |
President, Global Technology and Product